Distribution of differences in numbers of anti-hypertensive medications prescribed between baseline and follow-up in Telescot diabetes trial participants by trial arm and...

BackgroundThe prevalence of type 2 diabetes among Malaysian adults has increased by more than two folds over the past two decades. Strategies to collaborate with the existing...

Patients’ baseline characteristics at baseline in intervention group, care as usual group and total sample.

Subjects´ and diseases´ characteristics at baseline.

Percentage of participants who met clinical recommendation of lifestyle changes.

Distribution of minimization criteria in all trial participants by trial arm (supported telemonitoring compared to usual care).

BackgroundSelf-monitoring of blood glucose among people with type 2 diabetes not treated with insulin does not appear to be effective in improving glycemic control. We...

Results of Cox proportional hazard regression models examining treatment group as a predictor of incident diabetes–alternative definitions of incident diabetes.

Characteristics of trial participants included in the primary endpoint analysis at baseline by trial arm (supported telemonitoring compared to usual care).

BackgroundImplementation of the COPD-Home integrated disease management (IDM) intervention at discharge after hospitalizations for acute exacerbations of COPD (AECOPD) led to...

Baseline socio-demographics and health characteristics of participants.

Logistic regression analysis of lower patient activation measure (PAM) score.

Data presented as median (interquartile range) or number (proportion).

Results of the mixed model analyses.

Baseline and follow-up values for primary and secondary outcomes in the trial by trial arm.

Distribution of differences in numbers of diabetes treatments prescribed between baseline and follow-up in Telescot diabetes trial participants by trial arm and initiation of...

Baseline clinical, physical activity, diet, and health-related quality of participants.

BackgroundWe developed and tested the effectiveness of a tailored health information technology driven intervention: “Talking Prescriptions” (Talking Rx) to improve medication...

Changes in outcomes from baseline to 6- and 12-month follow-up with differences in within and between groups over time.

The mean SGRQ, HADS, PAM scores and difference in score change over time.